Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode

Kurbaan, Arvinder S.; Bowker, Timothy J.; Ilsley, Charles; Sigwart, Ulrich; Rickards, Anthony F.

doi:10.1016/s0002-9149(01)01426-6

Cited by 100 publications

(42 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Hence, many of our patients with MS also had DM and most of the diabetic patients were classified as having MS among the population in which the type 2 DM resulted from obesity. Furthermore, the risk for increased mortality and morbidity of cardiovascular disease in patients with MS is associated with significant overlaps with DM, which is an established risk factor for a poor prognosis following PCI (13)(14)(15). From this viewpoint, risk assessment is warranted in patients with MS alone, DM alone, or both MS and DM.…”

Section: Discussionmentioning

confidence: 99%

Impact of Metabolic Syndrome among Patients with and without Diabetes Mellitus on Long-Term Outcomes after Percutaneous Coronary Intervention

et al. 2008

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Impact of Metabolic Syndrome among Patients with and without Diabetes Mellitus on Long-Term Outcomes after Percutaneous Coronary Intervention

et al. 2008

View full text Add to dashboard Cite

show abstract

“…Papers resulting from observational studies (records) were not considered. We identified a total of 26 randomized studies that met the requirements: RITA 1,2 , ERACI 3,4 , EAST [5][6][7] , GABI 8,9 , CABRI 10,11 , TOULOUSE 12 , BARI [13][14][15][16] , MASSI 17,18 , LAUSANNE 19,20 , ERACI II 21,22 , MASS II [23][24][25] , AWESOME 26,27 , OCTOSTENT 28 , LEIPZIG 29 , SIMA 30,31 , Drenth et al 32 , SOS 33,34 , ARTS 35,36 , LEMANS 37 , SYNTAX 38 , MYOPROTECT 39 , Hong et al 40 , Kim et al 41 , Cisowski et al 42 , AMIST 43 and CÁRDia 44 .…”

Section: Methods Selection and Characteristics Of The Studiesmentioning

confidence: 99%

Angioplastia coronariana versus cirurgia de revascularização: revisão de estudos randomizados

Andrade

Medeiros

Andrade

et al. 2011

Arq. Bras. Cardiol.

View full text Add to dashboard Cite

We carried out a review that included results of randomized trials that made a comparison between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). The 25 selected trials involved 12,305 patients, 11,103 of whom were from studies in patients with multi-vessel disease and 1,212 were from studies in patients with single lesion of the left anterior descending (LAD). In the studies of multivessel disease patients, the PCI showed a trend towards lower early mortality (1.2% versus 2%) and lower incidence of stroke: 0.7% versus 1.65%. There was no difference in the intermediate mortality (3.8% versus 3.8%). There was a trend towards the superiority of CABG in late mortality (10.5% versus 9.6%). The difference was exclusively due to "balloon era" studies, with a trend towards an inversion in the "stent era" (9.6% versus 9.9%). In studies of single lesion of LAD, there was no significant difference in any endpoint. The aggregation of results from nine studies that assessed late mortality in diabetic patients showed a difference in favor of surgery (21.3% versus 15.9%). Two studies that evaluated main coronary artery disease did not show a significant difference in mortality at one year (3.9% versus 4.7%). The incidence of repeat revascularization was consistently higher in PCI, despite the progressive improvement in results in the stent era.

show abstract

“…В 2007 г. Европейское общество кардиологов и Ев-ропейское общество по изучению сахарного диабета рекомендовали чрескожное вмешательство на коронарных артериях (ЧКВ) в качестве метода выбора реваскуляризации миокарда у больных ИБС на фоне СД. В основу Рекомендаций легли результаты трех крупных рандо-мизированных исследований: Randomized Intervention Treatment of Angina (RITA-1), Coronary Angioplasty versus Bypass Revascularisation Investigation (CABRI) и Emory Angioplasty versus surgery trial (EAST) [2][3][4], выполненных в годы применения баллонной ангиопластики коронарных артерий. Преимущества аорто-коронарного шунтиро-вания (АКШ) в сравнении с ЧКВ в приведенных исследованиях до-казаны не были.…”

Section: сахарный диабетunclassified

Interventional cardiology and diabetes mellitus: age of effective coronary heart disease treatment

Kalashnikov¹,

Bondarenko²,

Кузнецов³

et al. 2011

Diabetes mellitus

View full text Add to dashboard Cite

show abstract

Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode

Cited by 100 publications

References 24 publications

Impact of Metabolic Syndrome among Patients with and without Diabetes Mellitus on Long-Term Outcomes after Percutaneous Coronary Intervention

Impact of Metabolic Syndrome among Patients with and without Diabetes Mellitus on Long-Term Outcomes after Percutaneous Coronary Intervention

Angioplastia coronariana versus cirurgia de revascularização: revisão de estudos randomizados

Interventional cardiology and diabetes mellitus: age of effective coronary heart disease treatment

Contact Info

Product

Resources

About